|
1
|
Schofield R: The relationship between the
spleen colony-forming cell and the haemopoietic stem cell. Blood
Cells. 4:7–25. 1978.PubMed/NCBI
|
|
2
|
Krause DS and Scadden DT: A hostel for the
hostile: The bone marrow niche in hematologic neoplasms.
Haematologica. 100:1376–1387. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Korn C and Méndez-Ferrer S: Myeloid
malignancies and the microenvironment. Blood. 129:811–822. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Geyh S, Rodríguez-Paredes M, Jäger P,
Khandanpour C, Cadeddu RP, Gutekunst J, Wilk CM, Fenk R, Zilkens C,
Hermsen D, et al: Functional inhibition of mesenchymal stromal
cells in acute myeloid leukemia. Leukemia. 30:683–691. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Medyouf H: The microenvironment in human
myeloid malignancies: Emerging concepts and therapeutic
implications. Blood. 129:1617–1626. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Schepers K, Campbell TB and Passegué E:
Normal and leukemic stem cell niches: Insights and therapeutic
opportunities. Cell Stem Cell. 16:254–267. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Kumar A, Anand T, Bhattacharyya J, Sharma
A and Jaganathan BG: K562 chronic myeloid leukemia cells modify
osteogenic differentiation and gene expression of bone marrow
stromal cells. J Cell Commun Signal. 12:441–450. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Battula VL, Le PM, Sun JC, Nguyen K, Yuan
B, Zhou X, Sonnylal S, McQueen T, Ruvolo V, Michel KA, et al:
AML-induced osteogenic differentiation in mesenchymal stromal cells
supports leukemia growth. JCI Insight. 2:900362017. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Méndez-Ferrer S, Michurina TV, Ferraro F,
Mazloom AR, Macarthur BD, Lira SA, Scadden DT, Ma'ayan A,
Enikolopov GN and Frenette PS: Mesenchymal and haematopoietic stem
cells form a unique bone marrow niche. Nature. 466:829–834. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Frenette PS, Pinho S, Lucas D and
Scheiermann C: Mesenchymal stem cell: Keystone of the hematopoietic
stem cell niche and a stepping-stone for regenerative medicine.
Annu Rev Immunol. 31:285–316. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Sacchetti B, Funari A, Michienzi S, Di
Cesare S, Piersanti S, Saggio I, Tagliafico E, Ferrari S, Robey PG,
Riminucci M and Bianco P: Self-renewing osteoprogenitors in bone
marrow sinusoids can organize a hematopoietic microenvironment.
Cell. 131:324–336. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Song N, Gao L, Qiu H, Huang C, Cheng H,
Zhou H, Lv S, Chen L and Wang J: Mouse bone marrow-derived
mesenchymal stem cells inhibit leukemia/lymphoma cell proliferation
in vitro and in a mouse model of allogeneic bone marrow transplant.
Int J Mol Med. 36:139–149. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zhao Z, Tang X, You Y, Li W, Liu F and Zou
P: Assessment of bone marrow mesenchymal stem cell biological
characteristics and support hemotopoiesis function in patients with
chronic myeloid leukemia. Leuk Res. 30:993–1003. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Huang JC, Basu SK, Zhao X, Chien S, Fang
M, Oehler VG, Appelbaum FR and Becker PS: Mesenchymal stromal cells
derived from acute myeloid leukemia bone marrow exhibit aberrant
cytogenetics and cytokine elaboration. Blood Cancer J. 5:e3022015.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Fracchiolla NS, Fattizzo B and Cortelezzi
A: Mesenchymal stem cells in myeloid malignancies: A focus on
immune escaping and therapeutic implications. Stem Cells Int 2017.
67205942017.
|
|
16
|
Schroeder T, Geyh S, Germing U and Haas R:
Mesenchymal stromal cells in myeloid malignancies. Blood Res.
51:225–232. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Geyh S, Oz S, Cadeddu RP, Fröbel J,
Brückner B, Kündgen A, Fenk R, Bruns I, Zilkens C, Hermsen D,
Gattermann N, et al: Insufficient stromal support in MDS results
from molecular and functional deficits of mesenchymal stromal
cells. Leukemia. 27:1841–1851. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
von der Heide EK, Neumann M, Vosberg S,
James AR, Schroeder MP, Ortiz-Tanchez J, Isaakidis K, Schlee C,
Luther M, Jöhrens K, et al: Molecular alterations in bone marrow
mesenchymal stromal cells derived from acute myeloid leukemia
patients. Leukemia. 31:1069–1078. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Blau O, Hofmann WK, Baldus CD, Thiel G,
Serbent V, Schümann E, Thiel E and Blau IW: Chromosomal aberrations
in bone marrow mesenchymal stroma cells from patients with
myelodysplastic syndrome and acute myeloblastic leukemia. Exp
Hematol. 35:221–229. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Lopes MR, Pereira JK, de Melo Campos P,
Machado-Neto JA, Traina F, Saad ST and Favaro P: De novo AML
exhibits greater microenvironment dysregulation compared to AML
with myelodysplasia-related changes. Sci Rep. 7:407072017.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Wang EA, Rosen V, D'Alessandro JS, Bauduy
M, Cordes P, Harada T, Israel DI, Hewick RM, Kerns KM, LaPan P, et
al: Recombinant human bone morphogenetic protein induces bone
formation. Proc Nati Acad Sci USA. 87:2220–2224. 1990. View Article : Google Scholar
|
|
22
|
Scarfi S: Use of bone morphogenetic
proteins in mesenchymal stem cell stimulation of cartilage and bone
repair. World J Stem Cells. 8:1–12. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
He Y, Yu L, Liu J, Li Y, Wu Y, Huang Z, Wu
D, Wang H, Wu Z and Qiu G: Enhanced osteogenic differentiation of
human bone-derived mesenchymal stem cells in 3-dimensional printed
porous titanium scaffolds by static magnetic field through
up-regulating Smad4. FASEB J. 33:6069–6081. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Zhang Y, Chen B, Li D, Zhou X and Chen Z:
LncRNA NEAT1/miR-29b-3p/BMP1 axis promotes osteogenic
differentiation in human bone marrow-derived mesenchymal stem
cells. Pathol Res Pract. 215:525–531. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Vicente López MA, Vázquez García MN,
Entrena A, Olmedillas Lopez S, García-Arranz M, García-Olmo D and
Zapata A: Low doses of bone morphogenetic protein 4 increase the
survival of human adipose-derived stem cells maintaining their
stemness and multipotency. Stem Cells Dev. 20:1011–1019. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Toofan P and Wheadon H: Role of the bone
morphogenic protein pathway in developmental haemopoiesis and
leukaemogenesis. Biochem Soc Trans. 44:1455–1463. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zylbersztejn F, Flores-Violante M,
Voeltzel T, Nicolini FE, Lefort S and Maguer-Satta V: The BMP
pathway: A unique tool to decode the origin and progression of
leukemia. Exp Hematol. 61:36–44. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zhao X, Liu J, Peng M, Liu J and Chen F:
BMP4 is involved in the chemoresistance of myeloid leukemia cells
through regulating autophagy-apoptosis balance. Cancer Invest.
31:555–562. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Goldman DC, Bailey AS, Pfaffle DL, Al
Masri A, Christian JL and Fleming WH: BMP4 regulates the
hematopoietic stem cell niche. Blood. 114:4393–4401. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Voeltzel T, Flores-Violante M,
Zylbersztejn F, Lefort S, Billandon M, Jeanpierre S, Joly S,
Fossard G, Milenkov M, Mazurier F, et al: A new signaling cascade
linking BMP4, BMPR1A, DeltaNp73 and NANOG impacts on stem-like
human cell properties and patient outcome. Cell Death Dis.
9:10112018. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Bradham DM, Igarashi A, Potter RL and
Grotendorst GR: Connective tissue growth factor: A cysteine-rich
mitogen secreted by human vascular endothelial cells is related to
the SRC-induced immediate early gene product CEF10. J Cell Biol.
114:1285–1294. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Aguiar DP, de Farias GC, de Sousa EB, de
Mattos Coelho- Aguiar J, Lobo JC, Casado PL, Duarte ME and Abreu JG
Jr: New strategy to control cell migration and metastasis regulated
by CCN2/CTGF. Cancer Cell Int. 14:612014. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Jun JI and Lau LF: Taking aim at the
extracellular matrix: CCN proteins as emerging therapeutic targets.
Nat Rev Drug Discov. 10:945–963. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Chen CC and Lau LF: Functions and
mechanisms of action of CCN matricellular proteins. Int J Biochem
Cell Biol. 41:771–783. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Istvánffy R, Vilne B, Schreck C, Ruf F,
Pagel C, Grziwok S, Henkel L, Prazeres da Costa O, Berndt J,
Stümpflen V, et al: Stroma-derived connective tissue growth factor
maintains cell cycle progression and repopulation activity of
hematopoietic stem cells in vitro. Stem Cell Rep. 5:702–715. 2015.
View Article : Google Scholar
|
|
36
|
Mundy C, Gannon M and Popoff SN:
Connective tissue growth factor (CTGF/CCN2) negatively regulates
BMP-2 induced osteoblast differentiation and signaling. J Cell
Physiol. 229:672–681. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Johansen S, Brenner AK, Bartaula-Brevik S,
Reikvam H and Bruserud O: The possible importance of β3 integrins
for leukemogenesis and chemoresistance in acute myeloid leukemia.
Int J Mol Sci. 19:E2512018. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Al-Asadi MG, Brindle G, Castellanos M, May
ST, Mills KI, Russell NH, Seedhouse CH and Pallis M: A molecular
signature of dormancy in CD34+CD38- acute myeloid leukaemia cells.
Oncotarget. 8:111405–111418. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Wang J, Liu X, Qiu Y, Shi Y, Cai J, Wang
B, Wei X, Ke Q, Sui X, Wang Y, et al: Cell adhesion-mediated
mitochondria transfer contributes to mesenchymal stem cell-induced
chemoresistance on T cell acute lymphoblastic leukemia cells. J
Hematol Oncol. 11:112018. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Meads MB, Gatenby RA and Dalton WS:
Environment-mediated drug resistance: A major contributor to
minimal residual disease. Nat Rev Cancer. 9:665–674. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Winkler IG, Barbier V, Nowlan B, Jacobsen
RN, Forristal CE, Patton JT, Magnani JL and Lévesque JP: Vascular
niche E-selectin regulates hematopoietic stem cell dormancy, self
renewal and chemoresistance. Nat Med. 18:1651–1657. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Jacamo R, Chen Y, Wang Z, Ma W, Zhang M,
Spaeth EL, Wang Y, Battula VL, Mak PY, Schallmoser K, et al:
Reciprocal leukemia-stroma VCAM-1/VLA-4-dependent activation of
NF-κB mediates chemoresistance. Blood. 123:2691–2702. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Arber DA, Orazi A, Hasserjian R, Thiele J,
Borowitz MJ, Le Beau MM, Bloomfield CD, Cazzola M and Vardiman JW:
The 2016 revision to the World Health Organization classification
of myeloid neoplasms and acute leukemia. Blood. 127:2391–2405.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
World Medical Association: World Medical
Association Declaration of Helsinki: Ethical principles for medical
research involving human subjects. JAMA. 310:2191–2194. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Nielsen EØ, Chen L, Hansen JO, Degn M,
Overgaard S and Ding M: Optimizing Osteogenic differentiation of
ovine adipose-derived stem cells by osteogenic induction medium and
FGFb, BMP2, or NELL1 in vitro. Stem Cells Int 2018.
97813932018.
|
|
46
|
Liu X and Harada S: RNA isolation from
mammalian samples. Curr Protoc Mol Biol Chapter. 4:Unit 4.16. 2013.
View Article : Google Scholar
|
|
47
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Zor T and Selinger Z: Linearization of the
Bradford protein assay increases its sensitivity: Theoretical and
experimental studies. Anal Biochem. 236:302–308. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Dominici M, Le Blanc K, Mueller I,
Slaper-Cortenbach I, Marini F, Krause D, Deans R, Keating A,
Prockop Dj and Horwitz E: Minimal criteria for defining multipotent
mesenchymal stromal cells. The International Society for cellular
therapy position statement. Cytotherapy. 8:315–317. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Gribble SM, Roberts I, Grace C, Andrews
KM, Green AR and Nacheva EP: Cytogenetics of the chronic myeloid
leukemia-derived cell line K562: Karyotype clarification by
multicolor fluorescence in situ hybridization, comparative genomic
hybridization, and locus-specific fluorescence in situ
hybridization. Cancer Genet Cytogenet. 118:1–8. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Kouvidi E, Stratigi A, Batsali A, Mavroudi
I, Mastrodemou S, Ximeri M, Papadaki HA and Pontikoglou CG:
Cytogenetic evaluation of mesenchymal stem/stromal cells from
patients with myelodysplastic syndromes at different time-points
during ex vivo expansion. Leuk Res. 43:24–32. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Blau O, Baldus CD, Hofmann WK, Thiel G,
Nolte F, Burmeister T, Türkmen S, Benlasfer O, Schümann E, Sindram
A, et al: Mesenchymal stromal cells of myelodysplastic syndrome and
acute myeloid leukemia patients have distinct genetic abnormalities
compared with leukemic blasts. Blood. 118:5583–5592. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Soenen-Cornu V, Tourino C, Bonnet ML,
Guillier M, Flamant S, Kotb R, Bernheim A, Bourhis JH, Preudhomme
C, Fenaux P and Turhan AG: Mesenchymal cells generated from
patients with myelodysplastic syndromes are devoid of chromosomal
clonal markers and support short- and long-term hematopoiesis in
vitro. Oncogene. 24:2441–2448. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Jootar S, Pornprasertsud N, Petvises S,
Rerkamnuaychoke B, Disthabanchong S, Pakakasama S, Ungkanont A and
Hongeng S: Bone marrow derived mesenchymal stem cells from chronic
myeloid leukemia t(9;22) patients are devoid of Philadelphia
chromosome and support cord blood stem cell expansion. Leuk Res.
30:1493–1498. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Flores-Figueroa E, Montesinos JJ,
Flores-Guzmán P, Gutiérrez-Espíndola G, Arana-Trejo RM,
Castillo-Medina S, Pérez-Cabrera A, Hernández-Estévez E, Arriaga L
and Mayani H: Functional analysis of myelodysplastic
syndromes-derived mesenchymal stem cells. Leuk Res. 32:1407–1416.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Aanei CM, Flandrin P, Eloae FZ, Carasevici
E, Guyotat D, Wattel E and Campos L: Intrinsic growth deficiencies
of mesenchymal stromal cells in myelodysplastic syndromes. Stem
Cells Dev. 21:1604–1615. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Chandran P, Le Y, Li Y, Sabloff M, Mehic
J, Rosu-Myles M and Allan DS: Mesenchymal stromal cells from
patients with acute myeloid leukemia have altered capacity to
expand differentiated hematopoietic progenitors. Leuk Res.
39:486–493. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Reikvam H, Brenner AK, Hagen KM, Liseth K,
Skrede S, Hatfield KJ and Bruserud Ø: The cytokine-mediated
crosstalk between primary human acute myeloid cells and mesenchymal
stem cells alters the local cytokine network and the global gene
expression profile of the mesenchymal cells. Stem Cell Res.
15:530–541. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Mohammadi S, Nikbakht M, Sajjadi SM, Rad
F, Chahardouli B, Sabour Takanlu J, Rostami Sh, Alimoghaddam K,
Ghavamzadeh A and Ghaffari SH: Reciprocal interactions of leukemic
cells with bone marrow stromal cells promote enrichment of leukemic
stem cell compartments in response to curcumin and daunorubicin.
Asian Pac J Cancer Prev. 18:831–840. 2017.PubMed/NCBI
|
|
60
|
Becker PS: Dependence of acute myeloid
leukemia on adhesion within the bone marrow microenvironment.
ScientificWorldJournal 2012. 8564672012.
|
|
61
|
Konopleva M, Konoplev S, Hu W, Zaritskey
AY, Afanasiev BV and Andreeff M: Stromal cells prevent apoptosis of
AML cells by up-regulation of anti-apoptotic proteins. Leukemia.
16:1713–1724. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Nwajei F and Konopleva M: The bone marrow
microenvironment as niche retreats for hematopoietic and leukemic
stem cells. Adv Hematol 2013. 9539822013.
|
|
63
|
Damiano JS, Hazlehurst LA and Dalton W:
Cell adhesion-mediated drug resistance (CAM-DR) protects the K562
chronic myelogenous leukemia cell line from apoptosis induced by
BCR/ABL inhibition, cytotoxic drugs, and gamma-irradiation.
Leukemia. 15:1232–1239. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Aguiar DP, Coelho-Aguiar JM and Abreu JG:
CCN2/CTGF silencing blocks cell aggregation in embryonal carcinoma
P19 cell. Braz J Med Biol Res. 44:200–205. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Kumar A, Bhattacharyya J and Jaganathan
BG: Adhesion to stromal cells mediates imatinib resistance in
chronic myeloid leukemia through ERK and BMP signaling pathways.
Sci Rep. 7:95352017. View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Kojima K, McQueen T, Chen Y, Jacamo R,
Konopleva M, Shinojima N, Shpall E, Huang X and Andreeff M: p53
activation of mesenchymal stromal cells partially abrogates
microenvironment-mediated resistance to FLT3 inhibition in AML
through HIF-1α-mediated down-regulation of CXCL12. Blood.
118:4431–4439. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
67
|
Naugler WE and Karin M: The wolf in
sheep's clothing: The role of interleukin-6 in immunity,
inflammation and cancer. Trends Mol Med. 14:109–119. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
68
|
Rose-John S: IL-6 trans-signaling via the
soluble IL-6 receptor: Importance for the pro-inflammatory
activities of IL-6. Int J Biol Sci. 8:1237–1247. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
69
|
Fisher DT, Chen Q, Skitzki JJ, Muhitch JB,
Zhou L, Appenheimer MM, Vardam TD, Weis EL, Passanese J, Wang WC,
et al: IL-6 trans-signaling licenses mouse and human tumor
microvascular gateways for trafficking of cytotoxic T cells. J Clin
Invest. 121:3846–3859. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
70
|
Onishi K and Zandstra PW: LIF signaling in
stem cells and development. Development. 142:2230–2236. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
71
|
Itoh F, Watabe T and Miyazono K: Roles of
TGF-β family signals in the fate determination of pluripotent stem
cells. Semin Cell Dev Biol. 32:98–106. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
72
|
Conze D, Weiss L, Regen PS, Bhushan A,
Weaver D, Johnson P and Rincón M: Autocrine production of
interleukin 6 causes multidrug resistance in breast cancer cells.
Cancer Res. 61:8851–8858. 2001.PubMed/NCBI
|
|
73
|
Desbourdes L, Javary J, Charbonnier T,
Ishac N, Bourgeais J, Iltis A, Chomel JC, Turhan A, Guilloton F,
Tarte K, et al: Alteration analysis of bone marrow mesenchymal
stromal cells from de novo acute myeloid leukemia patients at
diagnosis. Stem Cells Dev. 26:709–722. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
74
|
Pontikoglou C, Kastrinaki MC, Klaus M,
Kalpadakis C, Katonis P, Alpantaki K, Pangalis GA and Papadaki HA:
Study of the quantitative, functional, cytogenetic, and
immunoregulatory properties of bone marrow mesenchymal stem cells
in patients with B-cell chronic lymphocytic leukemia. Stem Cells
Dev. 22:1329–1341. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
75
|
Ogden A, Rida PC, Knudsen BS, Kucuk O and
Aneja R: Docetaxel-induced polyploidization may underlie
chemoresistance and disease relapse. Cancer Lett. 367:89–92. 2015.
View Article : Google Scholar : PubMed/NCBI
|
